Company
United StatesAspire Pharmaceuticals, Inc., Somerset, NJ – FDA Inspections
Inspection records and compliance data for Aspire Pharmaceuticals, Inc. in Somerset, New Jersey. 5 FDA inspections on record, 2 Form 483s, 1 warning letter, last inspected April 24, 2026.
Company Profile
This profile covers Aspire Pharmaceuticals, Inc. based in Somerset, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 3
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 2
- Warning letters
- 1
First inspected June 21, 2010. Last inspected April 24, 2026.
Most cited issue areas
- Personnel dating/signing equipment log1 inspection
- Quality control operations - product complaints; investigate1 inspection
- Quality control, review, approve; investigate, follow-up1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 24, 2026 | Not classified | Human Drugs · Drug Quality Assurance | 1301828 |
| July 14, 2023 | VAI | Foods & Cosmetics, Human Drugs · Drug Quality Assurance | 1214674 |
| June 1, 2017 | NAI | Foods & Cosmetics · Food Composition, Standards, Labeling and Econ | 1015293 |
| May 19, 2014 | VAI | Foods & Cosmetics · Food Composition, Standards, Labeling and Econ | 879027 |
| June 21, 2010 | VAI | Foods & Cosmetics · Food Composition, Standards, Labeling and Econ | 668387 |
FDA documents
Warning Letters (1)
People (5)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Aspire Pharmaceuticals, Inc.
FEI Number
3003159106
Address
37 & 41 Veronica Ave, Somerset, New Jersey 08873, United States
Country
United States
ID: a7f24f44-bab7-47c1-afe8-82174268bc8b